Andere Sprachen Biomerica, Inc.

Aktien

866251

US09061H3075

BMRA

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 31.05.2024			% 5 Tage	% 1. Jan.
0.5806 ^USD	-7.84%		-7.25%	-53.55%

13.05.	Biomerica, Inc. kündigt den Start des inFoods IBS-Pilotprogramms mit einer prominenten Ärztegruppe mit 1.100 Mitgliedern ab Juni 2024 an	CI
29.04.	Biomerica schließt Vertriebsvertrag für Heimscreening-Tests in den Vereinigten Arabischen Emiraten ab	MT

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Biomerica, Inc. Announces Infoods IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024	13.05.
Biomerica Enters Distribution Deal to Provide Home Screening Tests in UAE	29.04.
Biomerica and UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement	29.04.
Biomerica Provides Update on inFoods IBS Expansion	15.04.
Biomerica, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024	12.04.
Biomerica, Inc. Announces the Appointment of Gary Huff to Its Strategic Advisory Board	21.02.
Biomerica, Inc. Appoints Jack Kenny as Chairman of the Board of Directors	23.01.
Biomerica, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2023	16.01.
Top Premarket Decliners	19.12.
Biomerica, Inc. Receives US FDA 510(k) Clearance for their Hp Detect Stool Antigen ELISA Test Product Designed to Detect Presence of H. Pylori Bacteria	18.12.
Biomerica, Inc. Expands in Foods IBS Reach with Addition of Several New GI Groups	08.11.
Biomerica, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2023	12.10.23
Biomerica Says Dubai Approves Insurance Reimbursement for Colorectal Disease Screening Test	26.09.23
Jack Kenny Joins Biomerica?S Board of Directors	28.08.23
Biomerica, Inc. Reports Earnings Results for the Full Year Ended May 31, 2023	25.08.23
Biomerica's Colorectal Disease Screening Test to be Available in CVS Stores in September	03.08.23
Biomerica Inc. Receives Notice of Patent Allowance in China for A Potential Innovative Technology That Includes an Artificial Intelligence Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients	21.06.23
Biomerica Inc. Announces A Significant Advance in the Management of Irritable Bowel Syndrome	18.05.23
Biomerica, Inc. Announces inFoods IBS Test Now Available at Gastro Health	17.04.23
Biomerica, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2023	14.04.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Biomerica, Inc.

Aktien

866251

US09061H3075

BMRA

Andere Sprachen

Filter